Atea Pharmaceuticals, Inc. (AVIR)

Atea Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	95.71	64.7	143.82	188.46	764.38
Short-Term Investments	206.12	390.03	434.28	458.25	-
Cash & Short-Term Investments	301.83	454.72	578.11	646.71	764.38
Cash Growth	-33.62%	-21.34%	-10.61%	-15.39%	-10.09%
Other Current Assets	9.16	7.63	12.35	14.21	8.03
Total Current Assets	310.99	462.36	590.46	660.92	772.4
Net Property, Plant & Equipment	1.09	2.12	3.12	4.09	0.18
Other Long-Term Assets	3.14	0.2	1.4	1.69	0.31
Total Assets	315.22	464.67	594.97	666.71	772.89
Accounts Payable	12.95	4.46	4.25	2.55	4.53
Accrued Expenses	26	13.35	27.36	15.21	52.15
Current Portion of Leases	0.84	0.8	0.76	0.72	0.2
Total Current Liabilities	39.78	18.6	32.38	18.48	56.88
Long-Term Leases	-	0.84	1.64	2.4	-
Other Long-Term Liabilities	-	6.36	5.76	5.26	5.93
Total Long-Term Liabilities	-	7.2	7.4	7.66	5.93
Total Liabilities	39.78	25.8	39.78	26.14	62.82
Common Stock	0.08	0.08	0.08	0.08	0.08
Additional Paid-in Capital	797.75	802.77	750.74	701.05	653.96
Accumulated Other Comprehensive Income	0.17	0.23	0.21	-0.68	-
Retained Earnings	-	-	-195.84	-59.88	56.03
Shareholders' Equity	798	803.09	555.19	640.57	710.08
Total Liabilities & Equity	837.79	828.89	594.97	666.71	772.89
Total Debt	0.84	1.64	2.4	3.12	0.2
Net Cash (Debt)	300.99	453.08	575.7	643.59	764.18
Net Cash Growth	-33.57%	-21.30%	-10.55%	-15.78%	-10.11%
Net Cash Per Share	3.69	5.38	6.90	7.73	8.66
Book Value	798	803.09	555.19	640.57	710.08
Book Value Per Share	9.79	9.53	6.66	7.69	8.05
Tangible Book Value	798	803.09	555.19	640.57	710.08
Tangible Book Value Per Share	9.79	9.53	6.66	7.69	8.05

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q